Das Instrument 9NR NO0010331838 NORWAY ROYAL SALMON NK 1 EQUITY wird ex Kapitalmassnahme gehandelt am 04.04.2022
The instrument 9NR NO0010331838 NORWAY ROYAL SALMON NK 1 EQUITY is traded ex capital adjustment on 04.04.2022
Das Instrument C52 US1940141062 COLFAX CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 04.04.2022 und ex Kapitalmassnahme am 05.04.2022
The instrument C52 US1940141062 COLFAX CORP. EQUITY is traded cum capital adjustment on 04.04.2022 and ex capital adjustment on 05.04.2022
Das Instrument XTG ES0105065009 TALGO S.A. EO -,301 EQUITY wird ex Kapitalmassnahme gehandelt am 04.04.2022
The instrument XTG ES0105065009 TALGO S.A. EO -,301 EQUITY is traded ex capital adjustment on 04.04.2022
Das Instrument 4OMA US92531L2079 VERSO CORP. A DL -,01 EQUITY wird ex Kapitalmassnahme gehandelt am 04.04.2022
The instrument 4OMA US92531L2079 VERSO CORP. A DL -,01 EQUITY is traded ex capital adjustment on 04.04.2022
Das Instrument M4Z US55272X1028 MFA FINANCIAL INC.DL -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 04.04.2022 und ex Kapitalmassnahme am 05.04.2022
The instrument M4Z US55272X1028 MFA FINANCIAL INC.DL -,01 EQUITY is traded cum capital adjustment on 04.04.2022 and ex capital adjustment on 05.04.2022
Das Instrument 8F8 SE0008241491 SYNACT PHARMA AB EQUITY wird ex Kapitalmassnahme gehandelt am 04.04.2022
The instrument 8F8 SE0008241491 SYNACT PHARMA AB EQUITY is traded ex capital adjustment on 04.04.2022
Das Instrument PP21 US7127041058 PEOPLE'S UTD FINL DL -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 04.04.2022 und ex Kapitalmassnahme am 05.04.2022
The instrument PP21 US7127041058 PEOPLE'S UTD FINL DL -,01 EQUITY is traded cum capital adjustment on 04.04.2022 and ex capital adjustment on 05.04.2022
Das Instrument 4SF AU0000032377 BARDOC GOLD LTD EQUITY wird cum Kapitalmassnahme gehandelt am 04.04.2022 und ex Kapitalmassnahme am 05.04.2022
The instrument 4SF AU0000032377 BARDOC GOLD LTD EQUITY is traded cum capital adjustment on 04.04.2022 and ex capital adjustment on 05.04.2022
The instrument 9NR NO0010331838 NORWAY ROYAL SALMON NK 1 EQUITY is traded ex capital adjustment on 04.04.2022
Das Instrument C52 US1940141062 COLFAX CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 04.04.2022 und ex Kapitalmassnahme am 05.04.2022
The instrument C52 US1940141062 COLFAX CORP. EQUITY is traded cum capital adjustment on 04.04.2022 and ex capital adjustment on 05.04.2022
Das Instrument XTG ES0105065009 TALGO S.A. EO -,301 EQUITY wird ex Kapitalmassnahme gehandelt am 04.04.2022
The instrument XTG ES0105065009 TALGO S.A. EO -,301 EQUITY is traded ex capital adjustment on 04.04.2022
Das Instrument 4OMA US92531L2079 VERSO CORP. A DL -,01 EQUITY wird ex Kapitalmassnahme gehandelt am 04.04.2022
The instrument 4OMA US92531L2079 VERSO CORP. A DL -,01 EQUITY is traded ex capital adjustment on 04.04.2022
Das Instrument M4Z US55272X1028 MFA FINANCIAL INC.DL -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 04.04.2022 und ex Kapitalmassnahme am 05.04.2022
The instrument M4Z US55272X1028 MFA FINANCIAL INC.DL -,01 EQUITY is traded cum capital adjustment on 04.04.2022 and ex capital adjustment on 05.04.2022
Das Instrument 8F8 SE0008241491 SYNACT PHARMA AB EQUITY wird ex Kapitalmassnahme gehandelt am 04.04.2022
The instrument 8F8 SE0008241491 SYNACT PHARMA AB EQUITY is traded ex capital adjustment on 04.04.2022
Das Instrument PP21 US7127041058 PEOPLE'S UTD FINL DL -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 04.04.2022 und ex Kapitalmassnahme am 05.04.2022
The instrument PP21 US7127041058 PEOPLE'S UTD FINL DL -,01 EQUITY is traded cum capital adjustment on 04.04.2022 and ex capital adjustment on 05.04.2022
Das Instrument 4SF AU0000032377 BARDOC GOLD LTD EQUITY wird cum Kapitalmassnahme gehandelt am 04.04.2022 und ex Kapitalmassnahme am 05.04.2022
The instrument 4SF AU0000032377 BARDOC GOLD LTD EQUITY is traded cum capital adjustment on 04.04.2022 and ex capital adjustment on 05.04.2022